IRIS
GIALLONGO, CESARINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.571
NA - Nord America 1.539
AS - Asia 287
AF - Africa 256
SA - Sud America 4
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.660
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.487
IT - Italia 899
IE - Irlanda 285
CI - Costa d'Avorio 201
CN - Cina 178
UA - Ucraina 131
DE - Germania 58
RU - Federazione Russa 51
VN - Vietnam 50
CA - Canada 49
SN - Senegal 49
FR - Francia 35
GB - Regno Unito 27
SE - Svezia 27
JP - Giappone 16
BE - Belgio 13
NL - Olanda 11
CH - Svizzera 9
IN - India 9
KR - Corea 7
FI - Finlandia 6
NG - Nigeria 6
SG - Singapore 6
LB - Libano 5
GR - Grecia 4
HK - Hong Kong 4
IL - Israele 4
UZ - Uzbekistan 4
AT - Austria 3
MX - Messico 3
NO - Norvegia 3
AR - Argentina 2
AU - Australia 2
ES - Italia 2
LT - Lituania 2
AE - Emirati Arabi Uniti 1
BR - Brasile 1
CL - Cile 1
EU - Europa 1
GE - Georgia 1
HR - Croazia 1
IR - Iran 1
PL - Polonia 1
RO - Romania 1
RS - Serbia 1
SI - Slovenia 1
SY - Repubblica araba siriana 1
Totale 3.660
Salva come PNG Salva come JPEG
Città #
Chandler 453
Dublin 282
Catania 253
Abidjan 201
Jacksonville 155
Ashburn 103
Houston 73
Cambridge 68
Lawrence 68
Andover 64
Dakar 49
Rome 47
Florence 45
Dong Ket 44
Nanjing 42
Toronto 37
Des Moines 36
Bremen 25
Beijing 24
Wilmington 24
Boardman 23
Saint Petersburg 19
San Mateo 19
Falls Church 18
Nanchang 18
Misterbianco 17
Shenyang 16
Milan 15
Washington 15
Dearborn 14
Fukuoka 14
Brussels 13
Hebei 12
Messina 12
Palermo 12
Ottawa 11
Paris 11
Augusta 10
Jiaxing 9
Moscow 9
Seattle 9
Changsha 8
Tianjin 8
Hanover 7
Ragusa 7
Seoul 7
Turin 7
Abuja 6
Acireale 6
Den Haag 6
Hanoi 6
Torino 6
Vicenza 6
Bari 5
Floridia 5
Grafing 5
Lappeenranta 5
Padova 5
Aachen 4
Agrate Brianza 4
Capri Leone 4
Forcoli 4
Gallipoli 4
Guangzhou 4
Hong Kong 4
Jinan 4
Los Angeles 4
Munich 4
Pedara 4
Reggio Calabria 4
Tel Aviv 4
Ann Arbor 3
Fremont 3
Kunming 3
Lentini 3
Milazzo 3
Morgan Hill 3
Naples 3
Oslo 3
Redwood City 3
Singapore 3
Albino 2
Anzio 2
Bergamo 2
Bethesda 2
Buenos Aires 2
Cagliari 2
Caltagirone 2
Caltanissetta 2
Cuneo 2
Duncan 2
Edinburgh 2
Enna 2
Ferrara 2
Fort Worth 2
Franconville 2
Frankfurt Am Main 2
Giarre 2
Groningen 2
Latina 2
Totale 2.614
Salva come PNG Salva come JPEG
Nome #
α-Lipoic Acid Reduces Iron-induced Toxicity and Oxidative Stress in a Model of Iron Overload 132
Activity-Dependent Neuroprotective Protein (ADNP)-Derived Peptide (NAP) Counteracts UV-B Radiation-Induced ROS Formation in Corneal Epithelium 124
Heme oxygenase-1 nuclear translocation regulates bortezomib-induced cytotoxicity and mediates genomic instability in myeloma cells. 107
CXCL12/CXCR4 axis supports mitochondrial trafficking in tumor myeloma microenvironment 96
Biological properties of Cakile maritima Scop. (Brassicaceae) extracts 94
Heme Oxygenase Inhibition Sensitizes Neuroblastoma Cells to Carfilzomib 89
Antimicrobial and anti-proliferative effects of skin mucus derived from dasyatis pastinaca (Linnaeus, 1758) 78
Inhibition of TLR4 signaling affects mitochondrial fitness and overcomes bortezomib resistance in myeloma plasma cells 74
Focus on Osteosclerotic Progression in Primary Myelofibrosis 74
Effect of lipoic acid on the biochemical mechanisms of resistance to bortezomib in SH-SY5Y neuroblastoma cells 72
Ixazomib improves bone remodeling and counteracts sonic hedgehog signaling inhibition mediated by myeloma cells 65
Biological properties of itraconazole-SLN 64
Clobetasol modulates adult neural stem cell growth via canonical hedgehog pathway activation 64
Mitochondrial Functions, Energy Metabolism and Protein Glycosylation are Interconnected Processes Mediating Resistance to Bortezomib in Multiple Myeloma Cells 63
Bortezomib modulates CHIT1 and YKL40 in monocyte-derived osteoclast and in myeloma cells. 62
A cytoprotective role for the heme oxygenase-1/CO pathway during neural differentiation of human mesenchymal stem cells 62
Antiproliferative and Antiangiogenic Effects of Punica granatum Juice (PGJ) in Multiple Myeloma (MM) 61
Clobetasol promotes neuromuscular plasticity in mice after motoneuronal loss via sonic hedgehog signaling, immunomodulation and metabolic rebalancing 61
Immune off-target effects of Brentuximab Vedotin in relapsed/refractory Hodgkin Lymphoma 56
Biochemical and clinical relevance of alpha lipoic acid: antioxidant and anti-inflammatory activity, molecular pathways and therapeutic potential 54
Effects of imatinib mesylate in osteoblastogenesis 53
Role of 17β-Estradiol on Cell Proliferation and Mitochondrial Fitness in Glioblastoma Cells 52
SPARC expression in CML is associated to imatinib treatment and to inhibition of leukemia cell proliferation 51
TLR4 signaling drives mesenchymal stromal cells commitment to promote tumor microenvironment transformation in multiple myeloma 50
Correction: TLR4 signaling drives mesenchymal stromal cells commitment to promote tumor microenvironment transformation in multiple myeloma (Cell Death & Disease, (2019), 10, 10, (704), 10.1038/s41419-019-1959-5) 49
Effects of second-generation tyrosine kinase inhibitors towards osteogenic differentiation of human mesenchymal cells of healthy donors 48
PMN-MDSC and arginase are increased in myeloma and may contribute to resistance to therapy 47
Mesenchymal Stem Cells (MSC) Regulate Activation of Granulocyte-Like Myeloid Derived Suppressor Cells (G-MDSC) in Chronic Myeloid Leukemia Patients 46
Iron regulates myeloma cell/macrophage interaction and drives resistance to bortezomib 46
BORTEZOMIB INHIBITS OSTEOCLASTOGENESIS AND MODULATE CHIT1 AND YKL40 EXPRESSION 45
CIRCULATING ARGINASE-1 IN SERUM IS A NOVEL BIO-MARKERIN HODGKIN LYMPHOMA 45
Bortezomib Could Reduce Cell Viability by Activation of Heme Oxygenase 1 in Multiple Myeloma Cells 45
Plasticity of High-Density Neutrophils in Multiple Myeloma is Associated with Increased Autophagy via STAT3 45
Monocytic myeloid-derived suppressor cells as prognostic factor in chronic myeloid leukaemia patients treated with dasatinib 44
Biological properties of itraconazole-SLNs 44
Bortezomib Inhibits Osteoclastogenesis and Bone Resorption Through Modulation of CHIT1 and YKL40 Expression 42
Pericytes in microvessels: From “mural” function to brain and retina regeneration 42
Neuroactive molecules and growth factors modulate cytoskeletal protein expression during astroglial cell proliferation and differentiation in culture 41
High-density neutrophils in MGUS and multiple myeloma are dysfunctional and immune-suppressive due to increased STAT3 downstream signaling 41
MONOCYTIC MYELOID DERIVED SUPPRESSOR CELLS (M-MDSC) AS PROGNOSTIC FACTOR IN DASATINIB TREATED PATIENTS WITH CHRONIC MYELOID LEUKEMIA 40
Mesenchymal stromal cells in tumor microenvironment remodeling of BCR-ABL negative myeloproliferative diseases 39
Lactate Induces the Expressions of MCT1 and HCAR1 to Promote Tumor Growth and Progression in Glioblastoma 39
GRANULOCYTE-LIKE MYELOID DERIVED SUPPRESSOR CELLS ARE INCREASED IN MULTIPLE MYELOMA DUE TO IMMUNOLOGICAL DYSREGULATION OF MESENCHYMAL STEM CELLS 39
Hedgehog signaling pathways in multiple myeloma 38
BRIT1/MCPH1 expression in chronic myeloid leukemia and its regulation of the G2/M checkpoint. 38
Modulation of extracellular signal-related kinase, cyclin D1, glial fibrillary acidic protein, and vimentin expression in estradiol-pretreated astrocyte cultures treated with competence and progression growth factors 38
The Heme Oxygenase System in Hematological Malignancies 38
The prognostic value of the myeloid-mediated immunosuppression marker Arginase-1 in classic Hodgkin lymphoma. 38
Concomitant and feasible treatment with dasatinib and the anti-EGFR antibody cetuximab plus radiotherapy in a CML patient with multiple squamous neoplasias 38
In-vitro NET-osis induced by COVID-19 sera is associated to severe clinical course in not vaccinated patients and immune-dysregulation in breakthrough infection 38
Chitinase domain containing 1 increase is associated with low survival rate and M0 macrophages infiltrates in colorectal cancer patients 37
Clinical impact of the immunome in lymphoid malignancies: the role of Myeloid-Derived Suppressor Cells 37
Myeloid-derived suppressor cells in Chronic myeloid leukemia 35
Neuroprotective Role of α-Lipoic Acid in Iron-Overload-Mediated Toxicity and Inflammation in In Vitro and In Vivo Models 34
Nuclear translocation of Heme oxygenase-1 confers resistance to imatinib in chronic myeloid leukemia cells 34
OVEREXPRESSION OF ARGINASE AND PROK-2 MAKES NEUTROPHILS OF MULTIPLE MYELOMA DYSFUNCTIONAL AND IMMUNOSUPPRESSIVE 33
Proteomic analysis reveals autophagy as pro-survival pathway elicited by long-term exposure with 5-azacitidine in high-risk myelodysplasia 33
Electronic nicotine delivery systems exhibit reduced bronchial epithelial cells toxicity compared to cigarette: the Replica Project 33
BRIT1/MCPH1 expression in chronic myeloid leukemia and its regulation of the G2/M checkpoint 32
IMPAIRED NEUTROPHIL FUNCTION IN PATIENTS WITH ACUTE LEUKEMIA 31
Lactate Rewrites the Metabolic Reprogramming of Uveal Melanoma Cells and Induces Quiescence Phenotype 30
Imatinib increases cytotoxicity of melphalan and their combination allows an efficient killing of chronic myeloid leukemia cells 29
Lactate modulates microglia polarization via IGFBP6 expression and remodels tumor microenvironment in glioblastoma 28
LENALIDOMIDE TREATMENT IS ABLE TO RESTORE REGULATORY T CELLS IN MULTIPLE MYELOMA PATIENTS 28
Monocytic myeloid derived suppressor cells in hematological malignancies 28
Proteasome inhibitors as a possible therapy for SARS-CoV-2 27
Immunoproteasome Genes Are Modulated in CD34+ JAK2V617F Mutated Cells from Primary Myelofibrosis Patients 27
Lactate trafficking inhibition restores sensitivity to proteasome inhibitors and orchestrates immuno-microenvironment in multiple myeloma 26
Anaplastic thyroid cancer cells reduce CD71 levels to increase iron overload tolerance 25
Clinical outcome of SARS-CoV-2 infections occurring in multiple myeloma patients after vaccination and prophylaxis with tixagevimab/cilgavimab 25
Ruxolitinib treatment in myelofibrosis and polycythemia vera causes suboptimal humoral immune response following standard and booster vaccination with BNT162b2 mRNA COVID-19 vaccine 25
Myeloid derived suppressor cells (MDSCs) are increased and exert immunosuppressive activity together with polymorphonuclear leukocytes (PMNs) in chronic myeloid leukemia patients 25
Mitochondrial Bioenergetics at the Onset of Drug Resistance in Hematological Malignancies: An Overview 24
IGFBP-6/sonic hedgehog/TLR4 signalling axis drives bone marrow fibrotic transformation in primary myelofibrosis 23
The Role of Epigenetics in Neuroinflammatory-Driven Diseases 22
Granulocyte-like myeloid derived suppressor cells (G-MDSC) are increased in multiple myeloma and are driven by dysfunctional mesenchymal stem cells (MSC) 22
Overexpression of heme oxygenase-1 increases human osteoblast stem cell differentiation. 22
Pituitary Adenylate Cyclase-Activating Polypeptide Protects Corneal Epithelial Cells against UV-B-Induced Apoptosis via ROS/JNK Pathway Inhibition 20
Prediction of Survival and Prognosis Migration from Gold-Standard Scores in Myelofibrosis Patients Treated with Ruxolitinib Applying the RR6 Prognostic Model in a Monocentric Real-Life Setting 19
TLR4 Signaling and Heme Oxygenase-1/Carbon Monoxide Pathway Crosstalk Induces Resiliency of Myeloma Plasma Cells to Bortezomib Treatment 19
The Role of Inflammation and Inflammasome in Myeloproliferative Disease 19
Myelofibrosis and Survival Prognostic Models: A Journey between Past and Future 18
IGFBP-6: At the Crossroads of Immunity, Tissue Repair and Fibrosis 17
Uveal melanoma cells elicit retinal pericyte phenotypical and biochemical changes in an in vitro model of coculture 17
Deficiency and haploinsufficiency of histone macroH2A1.1 in mice recapitulate hematopoietic defects of human myelodysplastic syndrome 15
ACVR1: A Novel Therapeutic Target to Treat Anemia in Myelofibrosis 13
The pharmacotherapeutic management of patients with myelofibrosis: looking beyond JAK inhibitors 12
MacroH2A1.1 as a crossroad between epigenetics, inflammation and metabolism of mesenchymal stromal cells in myelodysplastic syndromes 12
Correction to: Neuroprotective Role of α-Lipoic Acid in Iron-Overload-Mediated Toxicity and Inflammation in In Vitro and In Vivo Models (Antioxidants, (2022), 11, 8, (1596), 10.3390/antiox11081596) 11
The Pleiotropic Effects of Fumarate: From Mitochondrial Respiration to Epigenetic Rewiring and DNA Repair Mechanisms 5
Engagement of Mesenchymal Stromal Cells in the Remodeling of the Bone Marrow Microenvironment in Hematological Cancers 4
IMMUNE ESCAPE MECHANISMS IN HEMATOLOGICAL DISEASES: ROLE OF THE MYELOID DERIVED SUPPRESSOR CELLS AND TUMOR MICROENVIRONMENT 4
Totale 3.831
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.594
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.594
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201932 0 0 0 0 0 0 0 0 0 0 10 22
2019/2020460 100 35 44 33 52 16 36 11 37 20 49 27
2020/2021466 19 19 35 32 111 16 61 11 30 7 49 76
2021/2022653 41 77 10 4 116 26 101 49 51 31 18 129
2022/20231.368 96 112 40 144 111 188 19 237 267 44 71 39
2023/2024681 55 140 39 40 47 203 40 88 4 25 0 0
Totale 3.831